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Background: Glioblastoma multiforme (GBM) is a highly aggressive form of brain cancer 
with marginal survival rates. GBM extracellular acidosis can profoundly impact its cell fate 
heterogeneities and progression. However, the molecules and mechanisms that enable 
GBM tumor cells acid adaptation and consequent cell fate competencies are weakly 
understood. Since extracellular proton concentrations (pHe) directly intercept the tumor 
cell plasma membrane, surface lipids must play a crucial role in pHe-dependent tumor 
cell fate dynamics. Hence, a more detailed insight into the finely tuned pH-dependent 
modulation of surface lipids is required to generate strategies that can inhibit or surpass 
tumor cell acid adaptation, thereby forcing the eradication of heterogeneous oncogenic 
niches, without affecting the normal cells.
results: By using image-based single cell analysis and physicochemical techniques, 
we made a small-scale survey of the effects of pH ranges (physiological: pHe 7.4, low: 
6.2, and very low: 3.4) on LN229 glioblastoma cell line surface remodeling and analyzed 
the consequent cell fate heterogeneities with relevant molecular targets and behavioral 
assays. Through this basic study, we uncovered that the extracellular proton concentra-
tion (1) modulates surface cholesterol-driven cell fate dynamics and (2) induces ‘differ-
ential clustering’ of surface resident GM3 glycosphingolipid which together coordinates 
the proliferation, migration, survival, and death reprogramming via distinct effects on the 
tumor cell biomechanical homeostasis. A novel synergy of anti-GM3 antibody and cyclo-
philin A inhibitor was found to mimic the very low pHe-mediated GM3 supraclustered 
conformation that elevated the surface rigidity and mechano-remodeled the tumor cell 
into a differentiated phenotype which eventually succumbed to the anoikis type of cell 
death, thereby eradicating the tumorigenic niches.
conclusion and significance: This work presents an initial insight into the physico-
chemical capacities of extracellular protons in the generation of glioblastoma tumor 
cell heterogeneities and cell death via the crucial interplay of surface lipids and their 
conformational changes. Hence, monitoring of proton–cholesterol–GM3 correlations 
in vivo through diagnostic imaging and in vitro in clinical samples may assist better tumor 
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inTrODUcTiOn
Extracellular tumor acidification (pHe) is a well-recognized 
hallmark of cancer progression (1–6).
Consolidated information from several studies has brought 
forth the knowledge that tumor masses can demonstrate het-
erogeneous pHe levels ranging from 7.4 to 6.2 units, in general, 
that can fall as low as 5.5–3.4 units and even below (1–9). This 
is essentially due to several factors such as nutrient starvation, 
oxidative stress, hypoxia, and high glucose, which tune cancer 
cells to anaerobic glycolysis, resulting in a high buildup of an acid 
equivalent of lactate, which is then extruded to the extracellular 
environment generating high proton concentrations (10).
The glioblastomas are characterized by four main tumor 
zones with distinct cellular phenotypes that are histopatho-
logically discernable (http://glioblastoma.alleninstitute.org/, 
follow ‘documentation tab’ and ‘overview’ under document 
sub-section). Figure 1A diagrammatically represents the differ-
ential pH microenvironments that may develop in these zones. 
The necrotic zone shows exfoliating and dying cells. This zone 
is reported to be formed due to overcrowding of high metaboli-
cally active cells, which extrude protons into the external tumor 
milieu leading to a dramatic lowering of the microenvironmental 
pH (approximately pH < 5.5–3.4 and even below). The necrotic 
zone is circumvented by slow migrating, large, and swollen 
‘Pseudo-palisading Cells’ (approximately pH < 5.5). Beyond this 
zone is the ‘Cellular Tumor’ zone where pH microenvironment 
varies from approximately 7.0 to 6.2 units, and tumor cells show 
various survival adaptations and cell fate heterogeneities. The 
well-vascularized tumor margins (approximately pH 7.4–7.2) 
are essentially characterized by fast migrating and invasive cells, 
hence known as the ‘Leading Edge.’
In acidic extracellular microenvironment (pHe), differential 
proton concentrations directly intercept the tumor cell surface. 
In the case of physiologically pH-adapted cells, such as those 
lining the kidney and gastric lumen, a high surface residency 
of cholesterol and GM3 glycosphingolipid is observed (Figure 
S1 in Supplementary Material) (11–13), which is probably to 
prevent the acid facing cellular membrane from proton-mediated 
hydrolysis. Interestingly, in tumor cells too, the biosynthesis of 
both cholesterol and GM3 is reported to be enhanced (14–17). 
However, how surface lipids such as cholesterol and GM3, the 
major components of the plasma membrane, fine tunes the tumor 
cell fate adaptations and heterogeneities in response to varying 
pHe is not yet understood.
Hence in this study, we have specifically addressed: (1) how 
extracellular protons can work to generate differential glio-
blastoma/tumor cell fates, that is, what cell fates competence is 
associated with which extracellular pH ranges and (2) whether 
extracellular proton concentrations differentially modify cho-
lesterol and GM3 biophysical and molecular properties that can 
crucially impact the intratumoral cell fate heterogeneities?
Toward this, we needed to test (i) the biophysical–biochemical 
capacities of protons, (ii) the differential cell fates they generate, 
and (iii) how surface cholesterol and GM3 participate in this 
process. To further explore the corroboration of our in  vitro 
observations with GBM pathology, we examined the GBM 
patient data, as distinct histopathological zones of GBMs are 
presumptively associated with certain pH microenvironments 
(diagrammatically shown in Figure 1A). This attempt was made 
in the light of a recently published study where presumptive low 
pH zones in breast cancer tissues were identified to be associated 
with enhanced LAMP2 surface localization in vivo and extracel-
lular acidification was shown to generate the same effect in vitro 
(18). Later, the authors measured the in vivo tumor pH and con-
cluded that LAMP2 enhanced expression and plasma membrane 
localization highlights the regions of progressive tumor acidosis 
(18, 19).
We too found that LAMP2 surface localization was signifi-
cantly enhanced in the regions attributed with ‘very low’ (necrotic 
zone) and ‘low pH’ (pseudo-palisading and cellular tumor zones) 
in the glioblastoma patient samples (Figure 1B) [US Biomax glio-
blastoma tissue arrays containing 63 distinct patient samples were 
processed for this analysis; here, ‘R’ denotes the colocalization 
coefficient between wheat germ agglutinin (binds to cell surface 
marker) and LAMP2 surface localization]. Hence, to some 
extent, extrapolation of acidosis-driven in  vitro observations 
with comparable evidences in different tumor zones of GBM 
patient samples may be relevant in this study and may present 
fresh insights into the development of the therapeutic strategies/
diagnostic biomarkers from the results obtained.
MaTerials anD MeThODs
chemicals and reagents
All fluorescent probes were purchased from Thermo Fisher 
Scientific (USA) and other common chemicals from Sigma 
Inc. (St. Louis, MO, USA); cyclophilin A inhibitor was from 
Calbiochem (Cat no-239836). LN229 cell line used here is a p53 
mutant, PTEN wild type, and was purchased from ATCC, USA. 
It is derived from aggressive, metastatic and grade IV (WHO) 
glioblastoma. It is an often used GBM cell line in acidosis and 
other glioblastoma-related studies (20–23). Other normal and 
tumor cell lines used in this study were also from ATCC, USA. 
All antibodies used in this study are detailed in Supplementary 
Material.
staging and prognosis. The emerged insights have further led to the translation of a 
‘pH-dependent mechanisms of oncogenesis control’ into the surface targeted anti-GBM 
therapeutics.
Keywords: extracellular ph dynamics, glycosphingolipid conformational heterogeneity, glioblastoma, antitumor 
therapy, cholesterol, gM3, cyclophilin a, surface clustering
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FigUre 1 | continued 
glioblastoma tumor zones and surface localization of laMP2 as a biomarker of progressive acidosis in each zone. (a) Diagrammatic representation of 
the glioblastoma tumor zones and the approximate pH ranges associated with each zone: necrotic zone (pH < 5.5–3.4), pseudo-palisading cells layer (pH 
approximately 5.5 or less), cellular tumor zone (pH < 7.0–6.2), and the leading edge or the tumor margins (pH < 7.4–7.2). (B) The glioblastoma multiforme (GBM) 
patient tissues were probed for surface marker wheat germ agglutinin (WGA, Alexa 598 labeled, red) and LAMP2 (an acidosis marker, green). A change in surface 
residency of LAMP2 in different tumor zones was estimated quantitatively by colocalization coefficient values (R) between WGA and LAMP2 staining. Qualitative 
significance was obtained by scoring the ‘Staining’ into high, medium, and low categories. ‘Intensity’ of expression was classified into strong, moderate, and weak. 
The number of ‘distinct GBM patient tissues’ considered for analysis of each tumor zone is indicated in the figure. Note that the average R values were derived from 
sample size for each tumor zone* three technical replicates. Also, note that there was a ‘very high’ surface localization of LAMP2 in the necrotic zones and ‘high’ 
localization in pseudo-palisading and cellular tumor zones. LAMP2 colocalized well with WGA in these zones, suggesting that more acidic tumor zones have high 
surface LAMP2 in GBMs.
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Molecular simulations
A series of atomic-scale molecular dynamic simulations were 
carried on the lipid bilayer comprising of 16 AcGM3 and 146 
POPC molecules for three different pHs: 7.4, 6.2, and 3.4. This 
allowed us to study the conformation and organization of the 
glycan headgroup of GM3 on bilayer normal at different pHs in 
a systematic manner. The simulation was performed using the 
GROMACS molecular dynamics package (for further details, 
please see Section ‘Methods and Materials’ in Supplementary 
Material) (24–27).
cell culture and In Vitro acidification 
Protocol
Briefly, cells were seeded for 16  h in DMEM (high glucose, 
Invitrogen, Cat No-12100-046) medium with 10% fetal bovine 
serum (Cat no. RM9955-500mL, HiMedia) and 1X antibiotic–
antimycotic solution (HiMedia-A002A). For 8-well chamber 
slides, seeding density was kept at 8 × 104 cells per well; for 6-well 
plates, initial cell density was 2.8 × 106, and for 96- and 24-well 
plates, the seeding densities were 104 and 4.8 × 104, respectively. 
The cells were subsequently incubated in serum-free DMEM 
(high glucose) medium with 1X antibiotics for 2  h for serum-
derived signal downregulation. The medium was then replaced 
with DMEM (high glucose) supplemented with 100  ng/ml of 
recombinant epidermal growth factor and adjusted to pH 7.4, 6.2, 
and 3.4. pH of the medium was adjusted with 2 N HCl. Cells were 
incubated at the specified pH units for 3 h, and then experimental 
sets were either treated with 10  µM methyl-beta-cyclodextrin 
(+veCD condition) or were left untreated in the respective pHs 
(−veCD condition). Cells were given these treatments for 2 h and 
were either then fixed with 1.5% PFA for immunocytochemistry 
or were processed for other assays as described in Supplementary 
Material. Each condition in the experimental sets (−veCD and 
+veCD) was kept in triplicate for the derivation of statistics and 
significance of data.
statistics
All above experiments were performed in triplicates. Each 
independent experiment had three technical replicates. Error 
bars are indicative of average SDs obtained across three inde-
pendent experimental sets. The p values were obtained through 
Bonferroni’s t-test between pH 7.4 units −veCD condition and 
other pH conditions and were represented as *p ≤ 0.05, **p ≤ 0.01, 
and ***p ≤  0.001, respectively. In individual situations, other 
comparisons of significance were also indicated. Image analysis 
was done on over 200 cells in each condition using Fiji image 
processing software. Calibration bar for LUT converted images 
were shown in the respective figures.
Please see Supplementary Material for further details on image 
analysis schema and other common methods used in this study.
resUlTs
ln229 glioblastoma Tumor cells show 
Differential Phenotypes and levels of 
surface cholesterol in response to 
extracellular ph ranges
Acid stress experiments have been successfully employed to 
understand cellular responses to both the intracellular (pHi) and 
extracellular pH (pHe) shifts (28–30).
We chose pH of 7.4, 6.2, and 3.4 units as representatives of 
physiological (pH 7.4), low (pH 6.2), and very low (pH 3.4) pro-
ton concentration ranges for further studies on pH-associated 
oncogenic vs. non-oncogenic transformations. Briefly, by about 
6  h, physiological pH range 7.4 showed well spread out and 
spindle-shaped morphologies (Figure  2A). Low pH range 
of 6.2  units showed both spindle-shaped cells and rounded 
phenotypes (associated with proliferative morphologies) (31, 
32) and ‘very low’ pH range of 3.4  units showed progressive 
cellular aggregations, formation of pseudo-luminal areas 
indicated by L, and release of small vesicles-indicated by yellow 
arrows. Cells in pH range 3.4 also showed extensive liberation 
of micrometer-sized blebs that got detached from the cells and 
were seen floating freely into the medium, indicating buildup 
of high hydrostatic pressure at very low pH (cyan and yellow 
arrows in Figure  2B, white arrows and insets in Figure  2A) 
(33, 34). It is to be noted that in pH 3.4, the cells remained 
adhered for 3 days and beyond this, a slow peeling began to take 
place. However, when the tumor cells growing at low and very 
low pH were exposed to physiological pH medium, the cells in 
pH 3.4 showed 100% rapid anoikis, suggesting that very low 
pH-adapted cells cannot recover to physiological phenotype 
(Figure 2C). This observation supports the reports that buffer 
therapy may kill low pH-adapted cells (35). It is to be further 
noted that tumor cells adapted to pH 6.2, did not show any signs 
of anoikis in the recovery experiments. When such peeled/
FigUre 2 | continued
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anoikis cells (pH 3.4 cultures re-exposed to pH 7.4 medium) 
were collected and re-plated in the physiological medium, they 
failed to show any residual growth or anastasis when followed 
for several days (36, 37).
Pyknotic nuclear morphology, an indicator of apoptotic cell 
death, was not observed in tumor cells adapted to different pHs 
(Figure  2D). Lack of ladder formation in DNA fragmentation 
assay also indicated that cells were not undergoing apoptosis even 
FigUre 2 | continued 
extracellular ph impacts glioblastoma tumor cell phenotype and suggests a possible association with cholesterol biosynthesis. (a) LN229 
glioblastoma tumor cell phenotype was monitored at pH 7.4 (physiological), pH 6.2 (low), and pH 3.4 (very low) for 24–72 h (data are shown for different time 
intervals in 24 h). Tumor cells at pH 7.4 and 6.2 showed spindle and rounded morphologies, while cells at pH 3.4 showed coagulation and release of small (yellow 
arrows) and large blebs (white arrows, see inset). Panel (B) shows zoomed images of small (yellow arrows) and large blebs (cyan arrows) formed at pH 3.4. (c) In 
recovery experiments, pH 3.4 exposed cells showed 100% de-adhesion and anoikis when reverted to physiological pH. (D) The nuclear morphology was not 
pyknotic in any pH range when monitored for 24 h, suggesting that no apoptosis was induced in low and very low pH ranges, in the time frame of the study. 
Additional supporting data for non-prominence of apoptosis, autophagy, and senescence at various pHs are described in Figures S2 and S3 in Supplementary 
Material. (e) LAMP2, a surface marker of progressive acidosis in breast cancer cells also showed significant surface localization in LN229 glioblastoma cells at low 
(pH 6.2) and very low pH (3.4) ranges, see colocalization coefficient (R) values between surface marker wheat germ agglutinin (WGA) and LAMP2. (F) HPA 
high-grade glioma patient data showed strong expression of LAMP2 (acidosis marker) and HMGCR (a rate-limiting enzyme in cholesterol biosynthesis) in necrotic/
pseudo-palisading and cellular tumor zones. These zones are in general associated with very low and low pHs, respectively (see Figure 1a). The expression 
comparisons were made in the samples from the same patients. For comparisons in more patients, see Figure S4 in Supplementary Material. (g) TCGA 
glioblastoma patient microarray data too showed more than twofold increase in mRNA expression of major cholesterol synthesizing enzymes.
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though cleaved caspase-3 levels were slightly high at pH 3.4 in 
comparison to other pH ranges (Figures S2A,D in Supplementary 
Material). Furthermore, cleaved PARP1, cleaved caspase-8, cell 
senescence, and autophagy markers also did not indicate promi-
nent activation of any of these processes in different pH ranges 
(Figures S2B,C and S3A–C in Supplementary Material). Note 
that cleaved caspases were observed to be sequestered near the 
inner surface of the plasma membrane at low and very low pHs, 
a localization that cannot induce apoptosis (38).
Localization of LAMP2 to the plasma membrane is recently 
evidenced to protect breast cancer cells from acidosis and 
surface hydrolysis (18). It is a new histopathological marker for 
progressive tumor acidosis, and its expression levels are seen to 
be much higher in low pH tumor zones. We found a proportion-
ate relocation of LAMP2 to the plasma membrane of LN229 
acid-adapted cells (Figure 2E), wherein high surface localization 
was observed in tumor cells exposed to low and very low pH. 
Human Protein Atlas (39, 40) data also showed high expression 
of LAMP2 protein (Figure  2F) in necrotic and peri-necrotic 
pseudo-palisading zones (cells resident in very low pH). ‘Cellular 
Tumor’ zone, generally at low pH, showed moderate expression, 
while the ‘Leading Edge,’ generally at near physiological pH, 
had low levels. Interestingly, HMGCR, a rate-limiting enzyme 
in cholesterol biosynthesis, showed high corroboration with the 
expression trend lines of LAMP2 in different tumor zones, when 
compared to the same patient samples (Figure  2F, for more 
patient data, please see Figure S4 in Supplementary Material). 
Similar, correlation was observed for LAMP2 and SREBF2 (a 
transcription factor that regulates HMGCR mRNA synthesis), 
Figure S5 in Supplementary Material. These observations cumu-
latively suggested that low and very low pH zones may upregulate 
cholesterol for efficient acid adaptation both in vitro and in vivo.
As mentioned earlier, in physiologically pH-adapted cells, 
high levels of cholesterol and GM3 were detected on the sur-
face (Figure S1 in Supplementary Material). This adaptation is 
proposed to prevent the cell membranes from acid hydrolysis, 
which is akin to mechanism suggested for LAMP2 function in the 
acid-adapted tumor cells. Hence, we first wanted to understand 
the role of cholesterol in tumor acid adaptation and cell fate 
transformations and then follow-up on GM3 glycosphingolipid.
TCGA mRNA transcript data from 538 GBM patients showed 
high upregulation of cholesterol synthesizing genes (Figure 2G, 
see more than twofold increase in expression levels of HMGCR 
and SREBF2). Further, significantly high expression and colo-
calization of LAMP2 and surface cholesterol were detected in 
necrotic and pseudo-palisading zones of GBM patient samples, 
followed by moderate expression and colocalization in ‘Cellular 
Tumor’ zone vs. the leading edge areas (Figure 3).
This initial analysis, hence suggested that low and very low 
pH zones may transport more cholesterol to the surface for acid 
adaption and survival.
extracellular Protons impact ln229 
glioblastoma Tumor cell Physicochemical 
Dynamics in a cholesterol-sensitive 
Manner
As discussed in the earlier section, there may exist a cross talk 
between the low pH interfacing cell surfaces and high surface 
cholesterol to shield tumor cells from acidosis. A significant rise in 
cholesterol was also observed when LN229 glioblastoma cell line 
was exposed to lower pH ranges of 6.2 and 3.4 units (Figure 4A; 
−veCD). The plasma membrane cholesterol quantitation was 
performed via imaging of signal from cholesterol binding nys-
tatin dye that was incubated on the surface of (i) live cells (kept 
on ice, to prevent endocytosis; cells were fixed after staining and 
imaged) and (ii) also post-fixation (Figure S6B in Supplementary 
Material). Similar results were obtained when measurements 
were made through fluorescence spectroscopy (Figure S6C in 
Supplementary Material).
When the glioblastoma cells in different pH microenviron-
ments were further perturbed with a very low concentration of 
methyl-beta-cyclodextrin (+veCD 10 µM) (37), a significant rise 
in cholesterol from its initial values was observed at all pH ranges 
(Figure 4A). This may be a feedback response to the initial loss in 
cholesterol by CD treatment, highlighting the need to maintain 
cholesterol levels in pH-graded tumor microenvironments. 
Hence, by this strategy, we were able to generate tumor cells with 
enhanced levels of cholesterol. This enabled us to study the effects 
of much higher levels of cholesterol on cell fate competencies in 
response to differential proton concentrations.
Cholesterol levels crucially determine surface rigidity/
anisotropy (41, 42). Surface rigidity is known to determine 
tumor cell fates (43). The low (6.2) and very low pH (3.4) 
FigUre 3 | glioblastoma patient data show an increase in surface cholesterol and significant association with laMP2, an acidosis marker protein. 
Three glioblastoma tissue arrays bearing tissues from the same patients (63 distinct patient tissues) were processed as technical replicates. The tissues were probed 
for WGA (surface marker WGA: wheat germ agglutinin, Alexa 598 labeled, shown in red); cholesterol (green); and LAMP2 (an acidosis marker, shown in magenta): a 
change in surface residency of cholesterol in ‘different tumor zones’ was estimated quantitatively by colocalization coefficient values (R) between WGA and 
cholesterol staining (yellow regions). Qualitative significance was obtained by scoring the ‘Staining’ into high, medium, and low categories. ‘Intensity’ of expression 
was scored in terms of strong, moderate, and weak. The total number of ‘distinct GBM patient tissues’ considered for analysis of each tumor zone was indicated in 
the figure. Note that the average R values were derived from sample size for each tumor zone* three technical replicates. Note that there was a high surface 
localization of cholesterol in necrotic and pseudo-palisading zones, while cellular tumor zones showed moderate expression. LAMP2 colocalized well with 
cholesterol in these zones (white areas, magenta + green), suggesting that more acidic tumor zones have high surface cholesterol.
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microenvironments in the unperturbed cholesterol condition 
(−veCD) showed enhanced surface anisotropy or rigidity, and 
this was further elevated in the high cholesterol conditions 
(+veCD) (Figure 4B).
Higher cholesterol levels increase the substrate adhesion 
energies for efficient mechanical load dissipation, and the gel 
contraction assay suggests that indeed high cholesterol pH 6.2 
+veCD gels contracted more and hence were far competent in the 
FigUre 4 | extracellular ph impacts ln229 glioblastoma tumor cell 
surface cholesterol levels and associated physical properties. Nystatin 
dye binds to cholesterol and hence enables its surface detection and 
quantitation. (a) Image-based quantitation of cholesterol via nystatin dye 
signal was performed in LN229 glioblastoma tumor cells. Data show an 
increase in surface cholesterol with decreasing pH. (B) Surface rigidity or 
anisotropy was measured through DPH dye polarization. A decrease in pH 
led to increase in surface rigidity. (c) Gel contraction assay showed that 
tumor cells with high surface cholesterol contracted more and were far 
competent in dissipating mechanical load. Error bar = SD; no. of 
independent experimental replicates = 3; *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001.
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dissipation of the mechanical force caused due to ECM–tumor 
cell interactions (Figure 4C) (44). Of note was that gels in pH 3.4 
microenvironments also contracted moderately, again suggesting 
that the cells in this pH condition were not dead but were under 
high membrane tension and could manage to moderately release 
tension by contracting. Further, gels devoid of cells, failed to 
contract in pH adjusted medium, confirming that contractility 
was produced by cells and not by the medium.
Surface rigidities and mechanical homeostasis directly deter-
mine tumor metabolic milieu (45, 46). The surface mechanical 
states are communicated to the chromatin via nuclear transloca-
tion of several surface resident mechanosensitive transcription 
factors that then enable appropriate adaptive modulations in 
cellular metabolic states. The cortical actin also relays the infor-
mation on the surface stiffness to the chromatin through stress 
fibers that are focally linked to the nuclear envelope. This further 
enables adaptive modulations in metabolic gene expressions (47). 
Besides, the surface stiffness also induces conformational changes 
in several metabolic enzymes to prevent their degradation. 
Surface rigidities crucially determines the trafficking of channels 
that maintain the pHi of the tumor cells to effect the functions of 
energy metabolism-associated proteins and enzymes, even in low 
extracellular pH conditions (48–51).
We find that low and very low pH microenvironments in 
−veCD and +veCD conditions showed higher intracellular 
alkalinity (Figure 5A) in comparison their respective external pH 
environments. Since most of the glycolysis-associated enzymes 
become inactive at very low pHi; this rise in intracellular pH was 
particularly important adaptation for tumor survival in low pH 
conditions. Surprisingly, cAMP, a known soluble mediator of 
bicarbonate channels, also showed high levels in ‘very low’ pH 
environment; hence, these tumor niches were rather quite suc-
cessful in maintaining very high pHi and cAMP pools for their 
survival (Figure 5B) (52, 53). We find that pH 6.2 had high glucose 
uptake which was significantly increased in higher cholesterol 
conditions at both pH 7.4 and 6.2 (Figure 5C). Cells at very low 
pH (3.4 units) had reduced glucose uptake and negligible levels 
of LDHA, a crucial enzyme in anaerobic glycolysis (Figure 5D). 
Although the observation on the absence of anaerobic glycolysis-
associated marker fits well with increased intracellular alkalinity 
at ‘very low’ pH, we wondered how tumor cells at pH 3.4 were able 
to generate high levels of ATP to sustain high levels of cAMP, if 
LDHA levels were low.
It came to our notice that macropinocytosis is an alterna-
tive mechanism by which cells drive excess nutrients from the 
extracellular microenvironment (54–56), and we observed that 
this phenomenon was enhanced at both ‘low’ and ‘very low’ pH 
microenvironments in −veCD conditions and at all pH ranges in 
+veCD-treated cells (Figure 5E) (as measured by the uptake of 
dextran–TMR, an assay to detect macropinosomes). Hence, high 
cholesterol and low pH microenvironments used multiple and 
heterogeneous pathways for active metabolism in comparison 
to tumor cells resident in pH 7.4 −veCD (basal cholesterol) 
condition.
extracellular Protons impacts ln229 
glioblastoma Tumor cell Fate Dynamics in 
a cholesterol-sensitive Manner
The physicochemical and metabolic remodeling via differential 
proton concentration may act as a stimulus for generation of 
heterogeneous tumor cell fate, a possibility that was further 
explored.
The BrdU-labeling index showed that high cholesterol tumor 
cells were proliferation competent and the high cholesterol pH 
6.2 condition was most proliferative (Figure  6A). However, to 
further examine whether different pH ranges also impact sub-
strate anchorage-independent proliferation and growth (that 
gradually evolves stem-like cells), we ran the soft agar anchorage-
independent growth assay (Figure 6B). Gliomaspheres incubated 
in the unperturbed cholesterol physiological pH condition were 
100% anchorage independent and lower pH treatments flattened 
the spheres, which de-promoted long-term anchorage-independ-
ent growth. The −veCD pH 6.2 condition showed approximately 
60% sphere flattening, probably due to an increase in cholesterol-
mediated surface rigidity. The +veCD conditions showed hetero-
geneous behavior with 60–70% flattening of spheres at pH of 7.4 
and 6.2 units, respectively. Notably, spheres at the ‘very low’ pH in 
all conditions showed flattened morphology without any further 
growth when monitored for three consecutive days. Hence, high 
cholesterol containing tumor cells, though more proliferative in 
2D cultures, were diminished of substrate-independent growth 
properties vs. the tumor cells growing in the unperturbed choles-
terol physiological pH condition (7.4 −veCD).
We further found that Oct4 (Figure 6C), an often used marker 
for substrate-independent growth, was diminished nuclearly in 
pH 6.2 −veCD condition and its total levels also dropped in 
FigUre 5 | extracellular ph impacts ln229 glioblastoma tumor cell biochemical homeostasis in a cholesterol-sensitive manner. Glioblastoma cells 
with basal and high surface cholesterol levels were incubated in various pH ranges. (a) Intracellular pH (pHi) in different extracellular pH (pHe) conditions was 
measured in live cells by using pH Rodo-based fluorescent microscopic imaging. (B) Cellular cAMP levels were measured by immunostaining. (c) Glucose uptake 
was measured by 2-NBDG assay. (D) LDHA, a crucial enzyme in anaerobic glycolysis, was measured by immunostaining and (e) Macropinocytosis was probed in 
live cells via dextran–TMR uptake assay. These assays enabled us to understand the overall cell energetics in different pH ranges. Error bar = SD; no. of 
independent experimental replicates = 3; *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001.
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the high cholesterol physiological and pH 6.2 conditions. Oct4 
showed reduced cytoplasmic accumulation in +veCD pH 7.4 
and 6.2 conditions but high accumulation in the cytoplasm at 
very low pH in all conditions, a phenotype also observed in the 
gastric cancers (57, 58) and glioblastoma biopsies (see expres-
sion in different tumor zones of GBM patient samples—Figure 
S7 in Supplementary Material). Reduction in nuclear Oct4 in 
high cholesterol conditions may be one of the major reasons for 
diminished anchorage-independent growth. Hence, Oct4 nuclear 
vs. non-nuclear localization in the response to pH and cholesterol 
levels may crucially determine differential cell fates. In fact, the 
cells at very low pH range showed very high upregulation of glial 
acid fibrillary protein, GFAP, a well-known marker of astrocyte 
differentiation (Figure  6D; see expression in different tumor 
zones of GBM patient samples—Figure S8 in Supplementary 
Material). Also, the distribution and concentration of GFAP 
protein at this pH were membranous and sub-membranous, 
while it was predominantly cytoplasmic in the other pH ranges. 
This suggests that ‘very low pH’ can program tumor cells toward 
differentiated and non-oncogenic fate.
While high cholesterol pH environment of 6.2 and 7.4 units 
excelled in proliferation and pH 3.4 in differentiation-like status, 
the wound healing assay showed a different ranking in migration 
competence of pH-graded microenvironments, with very low 
pH conditions being highly migration incompetent (Figure 6E). 
Tumor cells at physiological pH were most migration competent 
closely followed by cells growing in high cholesterol physiological 
pH microenvironments. However, tumor cells at pH 6.2  units 
migrated more slowly than physiological pH exposed cells 
(Figure 6E).
The migration competence showed high coroborration with 
enhanced colocalization of cortactin and vinculin at the focal 
adhesion structures in pH 7.4, as indicated by Pearson’s coefficient 
(R) (Figure 6F, white arrows, required for efficient migration). 
High R values indicated that the pH 7.4 microenvironment was 
intrinsically highly ‘metastasis competent.’ These observations are 
much supported by the evidence that tumor margins, essentially 
at near physiological pH are most migration competent (59, 60). 
Similar corroboration was derived from the other components of 
the focal adhesion such as the α-actinin–F-actin association, the 
levels of surface integrins, and its colocalization with the under-
lying alpha-tubulins and juxtapositioning of Rac1 to the inner 
leaflet of the plasma membrane, all of which generate an efficient 
migration competence (Figure S9 in Supplementary Material).
cholesterol Depletion impacts survival of 
low ph-adapted ln229 glioblastoma 
Tumor cells
Knowing that cholesterol levels in different pH microen-
vironments can crucially impact cell fates and growth, we 
decided to deplete the surface cholesterol from acid-adapted 
and non-acid-adapted tumor cells by treatment with 1  mM 
methyl-beta-cyclodextrin (MBCD/CD). Unlike 10 µM CD that 
FigUre 6 | extracellular ph impacts ln229 glioblastoma tumor cell proliferation vs. differentiation dynamics in a cholesterol-sensitive manner.  
(a) LN229 cells with basal and high surface cholesterol levels were subjected to different pH microenvironments and were then tested for the proliferation status via 
BrdU labeling. (B) Soft agar anchorage-independent growth assay was performed to examine the impact of various pH ranges on tumor cell self-renewal property. 
For this, live cell imaging of about 15–20 glioma spheres in each condition was followed for 3 days. (c) Immunostaining with OCT4, an often used marker of 
substrate-independent growth was performed and its nuclear vs. cytoplasmic localization at different pHs was compared in tumor cells. The in vitro observations on 
Oct4 immunostained patterns were also found to corroborate well with the patient data (please see Figure S7 in Supplementary Material). (D) GFAP, an astrocytic 
differentiation marker, showed significantly high levels in very low pH conditions. This observation was concordant with in vivo GFAP staining in necrotic and 
pseudo-palisading zones of glioblastoma multiforme tissues (Figure S8 in Supplementary Material). (e) The wound healing-based migration assay showed differential 
metastatic competence with varying pH microenvironments where very low pH condition promoted motility arrest. Tumor cells at physiological pH were most 
migration competent in both basal and high surface cholesterol conditions. Note that letter ‘S’ denotes the speed of migration of tumor cells and values of speed at 
36th and 60th hours is particularly highlighted. (F) Colocalization of cortactin and vinculin at migratory focal adhesion structures (highlighted with white arrows) in 
cells exposed to various pH is indicated by Pearson’s coefficient (R-value). Error bar = SD; no. of independent experimental replicates = 3; *p ≤ 0.05, **p ≤ 0.01, 
***p ≤ 0.001.
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enhances surface cholesterol levels by a feedback mechanism, 
1 mM and above concentrations of CD are shown to sequester 
cholesterol from surface permanently, in a dose-dependent 
manner (61). However, 1 mM MBCD/CD treatment is shown 
to be mild in normal cells (also tested by us, Figures  7D,E). 
We find (Figures  7A–C) that tumor cells resident in low pH 
(6.2) and very low pH (3.4) microenvironments began to peel 
off within 30 min of treatment and by about 1 h all the cells in 
pH 3.4 microenvironment had peeled off and showed necrosis. 
By about 3 h, all the cells in pH 6.2 microenvironment showed 
FigUre 7 | Depletion of surface cholesterol causes anoikis in low ph-adapted ln229 glioblastoma tumor cells. (a–c) LN229 glioblastoma cells with 
basal (−veCD) and high surface cholesterol level (+veCD) were exposed to different pH ranges and were then treated along with 1 mM CD (methyl-beta-cyclodextrin 
that removes cholesterol from the surface at mild to high concentrations). Normal cells: (D) mouse cerebellar granule neurons and (e) mouse cortical astrocytes 
were also treated with 1 mM CD. Within 48 h, 100% anoikis was observed only in glioblastoma cells at low and very low pH ranges. There was no visible anoikis in 
normal cells. Interestingly, glioblastoma cells growing at physiological pH were completely protected from this treatment. This suggests that removal of surface 
cholesterol makes low pH-adapted cells highly vulnerable to acid-mediated cytotoxicity. Note that mouse neurons and astrocytes were fixed after the experiment 
and labeled with Tuj1 and GFAP antibodies, respectively, to reveal morphologies clearly. The immunostained images are shown in grayscale. The experiment was 
repeated three times.
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the same effect while cells growing in physiological pH were 
unharmed. We collected the floating necrotic cells and upon 
centrifugation, pelleting and resuspension in the physiological 
medium, we re-plated the suspension in plastic dishes and 
on the soft agar. We did not find any evidence of residual cell 
revival/anastasis or recovery upon monitoring the cultures 
for next 7 days. Hence, the depletion of surface cholesterol in 
acid-adapted cells removed the protective shield and made cells 
vulnerable to acid-mediated toxicity and permanently killed 
them by anoikis. The very low pH (3.4)-adapted cells showed 
more rapid vulnerability to this treatment vs. the low pH 
(6.2)-adapted tumor cells.
extracellular Proton concentrations May 
induce gM3 glycosphingolipid 
conformational heterogeneity via the 
glycan Moiety
Since physiological pH-adapted tumor cells were unharmed 
by moderate cholesterol depletion (Figure  7A), we questioned 
whether GM3 glycosphingolipid, which is also seen to be high 
in acid-adapted cells, can be exploited to eradicate tumor cells in 
all pH microenvironments, including cells growing at the physi-
ological pH.
We began by running atomic level molecular dynamic simu-
lations of GM3–POPC in an asymmetric bilayer, to understand 
whether GM3 can respond to microenvironmental pH levels and 
thereby can act as a pH sensor and cell fate regulator. The density 
of hydrogen (H) bonds [Figure  8A: a–c (iii) shown as yellow 
dotted lines] in the outer leaflet containing GM3 was found to be 
progressively increased with a decrease in pH (from physiologi-
cal: pH 7.4, low pH: pH 6.2, to very low: pH 3.4). The H-bonds at 
pH 6.2 and 3.4 showed reduced vertical projection [Figure 8A: 
a–c (iii)] probably due to compactness of H-bonds. GM3 at 
the physiological pH, in contrast, basically had more vertical 
projections from the surface. This explanation was supported 
by the observations that glycan headgroup mainly stuck out of 
the plane of the bilayer at the physiological pH [Figure  8A: a 
(ii), see white arrow] which gradually tilted toward the bilayer 
with the decreasing pH values [Figure 8A: b,c (ii) indicated by 
white arrows]. The x–y projection of the simulations showed that 
due to increased H-bonding between glycans of GM3, there was 
an evolution of dimers at pH 6.2 and more clustered organiza-
tion at pH 3.4 (Figure 8A: e vs. f,g). A detailed analysis of the 
H-bonds between different glycans of the neighboring as well 
as self in GM3 revealed that GM3 H-bonds were predominantly 
established by the sialic acid [N-acetylneuraminic acid (NANA)] 
moieties at pH 6.2 and 3.4, followed by intermolecular interac-
tion via galactose (Gal) (see Table 1). However, at pH 7.4, the 
H-bonds were formed predominantly with water and the total 
numbers of intermolecular H-bonds per nanosecond were 
particularly low.
The results obtained by us in bi-component membrane simu-
lations at pH 7.4 are much in concert with the recent report on 
MSD data of GM3 clusters on complex lipid membranes (62). 
However, since our focus was also on the GM3 conformational 
patterns at the lower pH units, our MSD results suggests that 
acidic pHs can trigger a lipid shielding effect of Gal and NANA 
sugar moieties toward the POPC bilayer.
To further understand the basis of competence of different 
pHs in evolving GM3 receptor heterogeneity by local spatial 
changes in its glycan headgroups, we studied the tilt angles 
(Figure  8B; Figure S10 in Supplementary Material). While 
preferred tilt angle of glycans at pH 7.4 peaked at 50°, it peaked 
to 62° and 69° in pH 6.2 and 3.4, respectively. This suggests 
that at low pH, sialic acid can tilt more to find its surrounding 
binding partners. A look at the net effects of this pH-driven 
GM3 glycan conformational heterogeneity on its acyl chain 
orientation, that guides the membrane thickness, suggests 
that the membranes were progressively thicker at the lower 
pH units, indicative of stretched acyl chains in the membrane 
(Figure 8C).
FigUre 8 | gM3 demonstrates conformational heterogeneity in response to ph ranges. Panel (a) a–c (i) shows x–z projection of AcGM3 in GM3–POPC 
asymmetric bilayer. Panel (a) a–c (ii) shows single AcGM3 molecule average conformation in lipid bilayer at pH 7.4, 6.2, and 3.4, respectively. Panel (a) a–c (iii) 
shows outer leaflet-associated density and compactness of H-bonds (yellow dotted lines) of AcGM3 in vertical projections at pH 7.4, 6.2, and 3.4, respectively. 
Panel (a) e–g is the x–y projection of the simulations and shows GM3 monomers at pH 7.4, dimers at pH 6.2, and lipid clusters at pH 3.4. Panel (B) shows 
preferred tilt angle of GM3 glycan headgroup at various pH ranges. Panels (c,D) represent the effects of GM3 conformational heterogeneity (at different pH) on 
membrane thickness and lipid packing, respectively.
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We further investigated the compression of lipids per unit area 
in response to the decreasing pH. Results show that ‘area per lipid’ 
was reduced at low and very low pHs, suggesting an evolution of 
high lipid packing density. Hence, enhanced lipid packing at low 
pH and very low pH indicated the probability of high compres-
sional stress on the membrane (Figure 8D).
gM3 glycosphingolipid show In Vivo and 
In Vitro Differential surface clustering in 
glioblastomas
GM3 is highly expressed in gliomas and is shown to be 
a crucial component of the migratory complex (63, 64). 
TaBle 1 | phe gradient induced h-bond interactions in gM3–POPc 
bilayer and role of sialic acid.
acgM3
intermolecular h-bonding partners ph 3.4 ph 6.2 ph 7.4
NANA-NANA 0.19 0.17 0.04
Gal-Gal 0.17 – 0.02
Glc-Glc 0.01 – 0.04
Gal-NANA 0.07 0.05 0.02
Glc-NANA 0.06 0.08 0.08
SP-NANA – 0.02 –
SA-NANA – 0.02 –
NANA-POPC 0.15 0.16 0.09
Gal-POPC 0.05 0.07 0.09
Glc-POPC 0.11 0.18 0.20
SP-POPC 0.04 0.06 0.05
SA-POPC 0.01 0.01 0.02
Charge pairs 0.07 0.09 0.08
H-bonds with H2O 0.05 0.10 0.28
Average number (expressed in %) of intermolecular H-bonds and charge pairs between 
GM3–GM3, GM3–POPC, and GM3–water in systems at various pH. H-bonds formed 
per nanosecond were analyzed for last 100 ns in a 200-ns simulation. Each system 
consisted of 16 GM3, 143 POPC, and around 10,966 water molecules (error < 0.02). 
The expansion of terms used in table are as follows: NANA, sialic acid moiety of GM3 
(N-acetylneuraminic acid of acetyl GM3); Gal, galactose moiety of GM3; Glc, glucose 
moiety of GM3; SP, sphingosine lipid tail of GM3; SA, stearic acid lipid tail of GM3; 
POPC, 1-palmitoyl-2-oleoyl-phosphatidylcholine; charged pair species, dipole pairs 
within the molecule.
Bold font indicates the most significant values in the phenomenon studied.
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Immunohistochemistry from glioma patient revealed that 
GM3 is highly expressed in malignant glioblastomas and was 
well colocalized with cholesterol-rich regions in the WHO 
grade IV (Figure 9) cancers in both pediatric and adult patients 
vs. grade II (Figure S11 in Supplementary Material, see table 
embedded in the figure for comparative R values). GM3 was 
highly enriched in the necrotic and luminal zones where it 
showed large punctate/clustered patterns on the cellular surface 
(phenotypes designated by numbers 6 and 3) (Figures  9B,C, 
white arrow points to very low pH-associated nuclear mor-
phology as observed in Figure 2D). However, the non-luminal 
zones showed differential patterns where either a mix of large 
and small puncta were observed all over the cells (a phenotype 
designated by number 5) or small punctate and polarized 
clustered assemblies were noticed, suggestive of a polarized 
migratory phenotype (a  phenotype designated by number 4) 
(Figures  9D,E). Further, small phase separated clusters were 
observed in some tumor cells (phenotypes designated by num-
bers 1 and 2). All these patterns of GM3 were well correlated 
with the expression of cholesterol in the tumor cells and also 
with GM3 and cholesterol co-expression patterns in the human 
kidney and the gastric tissues which are the naturally acid-
adapted organs (Figure S1 in Supplementary Material). Hence, 
it appears that in a very low acidic environment, the tumor pH 
induces conformational changes in GM3 and simultaneously 
upregulates cholesterol to induce a lipid shielding effect against 
harsh acidic environment, which is generated by the extru-
sions of proton from the nutritionally starved and over-active 
tumor cells.
We were rather excited to see that the patterns obtained on the 
GBM patient tumor tissue sections strongly corroborated with 
the GM3 surface organization in our pH range in vitro studies 
(Figures 10A,B).
Overall, the unperturbed cholesterol conditions (−veCD) 
at physiological and low pH had reduced size and number of 
clusters, in comparison to the high cholesterol pH conditions, 
but pH 6.2 (−veCD) showed more number of clusters than 
pH 7.4 (−veCD), which was also predicted by our simulation 
data. Both GM3 cluster size and cluster fluorescence intensity 
that essentially denoted the number of expressing pixels in a 
cluster were found to be highly correlated in each condition 
(Figure 8B).
The high cholesterol tumor cells (+veCD) at physiological 
pH 7.4 showed numerous small sized GM3 clusters (0.17 μm2) 
that were organized in a polarized pattern. However, the pH 
6.2 exposed cells had comparatively fewer punctate clusters 
in the range of 0.17 μm2 but rather showed some larger sized 
clusters (0.34 μm2 and above), probably due to the high levels 
of cholesterol in these conditions. The few but larger clusters 
observed in pH 6.2 +veCD condition could have exerted a 
high compressional force on the tumor cells, forcing a spherical 
mitotic geometry, which might be the reason for the observed 
highest proliferative index of this condition (Figure  6A). The 
very low pH 3.4 exposed cells showed an evolution of very 
large sized clusters that almost appeared to cover the entire cell 
surface. Such very large numbers and sizes of GM3 clusters can 
exert very high compressional stress on tumor cells (as predicted 
in MSD data) which could have been responsible for the growth 
arrested phenotype at this pH.
The GM3 cluster size and intensity were highly diminished at 
all pH conditions from their original values in HQ (cytoskeleton 
disrupter) treated cells, suggesting that the major micron-sized 
GM3 clustering was cytoskeleton dependent. Since +veCD 
conditions also showed enhanced clustering, it can be assumed 
that micron-sized clusters were cholesterol and cytoskeleton 
dependent.
We confirmed that the clustering patterns obtained were not 
due to the cluster detection assay performed at a low temperature 
because in experiments where the cells that were first fixed at 
the room temperature and then probed for surface GM3 also 
showed similar surface patterns as seen when the GM3 antibody 
was incubated on the surface of live cells that were kept on ice, 
to prevent antibody endocytosis (Figure S12A in Supplementary 
Material). When live cells in different conditions were treated 
with saponin to deplete the surface cholesterol and then probed 
for surface GM3, the GM3 clustering pattern was highly reduced 
in all conditions at all pH units, again suggesting that cluster-
ing was sensitive to the levels of cholesterol (Figure S12B in 
Supplementary Material). We find that pH and cholesterol-driven 
GM3 differential clustering was specific and its precursor lipid 
species, lactosylceramide or another ganglioside SSEA4 (65) did 
not exhibit this type of clustering phenomena when exposed to the 
similar conditions (Figures S12C,D in Supplementary Material).
We further considered that the cholesterol-independent 
GM3–self-glycan interactions, as seen in lactonized forms, may 
FigUre 9 | continued
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FigUre 10 | ln229 glioblastoma tumor cell line shows variable gM3 surface clustering at different phe. (a) Tumor cells at various pH and with different 
surface cholesterol levels (−veCD and +veCD conditions) were incubated with the anti-GM3 antibody on ice for 45 min; cells were fixed and developed with a 
fluorescent secondary antibody to visualize GM3 organization on the plasma membrane. Also, to study the dependency of GM3 clusters on underlying actin, cells in 
different pH microenvironments in −veCD condition were treated with 50μM HQ to disrupt cytoskeleton. Images were captured with a confocal microscope and 
differential clustering patterns (size and intensity) were analyzed using Fiji software. Each image in panel (a) bears a number as an inset to describe the clustered 
pattern which matched with the patterns observed in glioblastoma multiforme patient tissues shown in Figure 9. No. 1 indicates small phase separated domains 
(shown with white stars) that are overall few in numbers; No. 2 indicates small phase separated domains (shown with white stars) that are overall more numerous than 
in pH 7.4 −veCD−veHQ condition. Thick white arrows in the image labeled as No. 3 indicates large punctate clusters; Thick white arrows in the images labeled as No. 
4 and No. 5 indicates dense polarized clusters, while thin arrows indicate smaller clusters. No. 5 image shows few large clusters too. No. 6 image shows very large 
and a few small clusters covering the entire surface of the cell. Thin arrows in No. 7 and No. 8 images indicate very small, diffuse, and less dense GM3 clustering.  
(B) Cluster size/area/cellular surface spread was analyzed in Fiji image processing software, and data were plotted using GraphPad Prism software, density of cluster 
was quantified via fluorescent intensity measurements. Error bar = SD; no. of independent experimental replicates = 3; *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001.
FigUre 9 | continued 
glioblastoma patient tissues reveal gM3 heterogeneous clusters with prominent supraclustering in prospective low ph zones.  
(a–e) Immunohistochemistry on (human) normal brain samples and glioblastoma grade IV patient tumor tissues was performed to probe the levels and organization 
of GM3 glycosphingolipid and its colocalization with cholesterol. (B–D) GM3 was enriched in necrotic zones, luminal, and peri-necrotic zones where it showed large 
punctate/clustered pattern on the cellular surface. (e) Non-luminal zones, cellular tumor zones showed differential patterns where either small puncta of GM3 were 
observed all over the cells, or GM3 polarized clustered assemblies were noticed, suggestive of a migratory phenotype. The white boxes in the panels and numbers 
alongside each box indicates distinct pattern of GM3 cluster organization. Note that the figure bears a reference number for each pattern which is described as 
follows—No. 1 is used for very few and small GM3 clusters; No. 2 is used for more but small clusters; No. 3 is used for large clusters dispersed all over the cell; No. 
4 is used for numerous but small and polarized clusters; No. 5 is used for small clusters with few large clusters dispersed all over the cell; and No. 6 is used for very 
large clusters covering the entire surface of the cell. Calibration bar for LUT converted images is shown alongside the image. Each glioblastoma multiforme patient 
tissue array consisted of 63 patient samples. Three samples showed medium GM3 staining while rest showed high GM3 levels on a visual scoring scheme of High, 
Medium and Low expression. R values indicate the extent of colocalization between GM3 and cholesterol in different zones of glioblastoma.
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also exist in low pH conditions, at least to some extent, and may 
contribute to observed GM3 clustering (17, 66). For this, we 
investigated the extent of contribution of low pH-induced GM3 
lactones (intra-glycan bonding between sialic acid and other sugar 
moieties) vs. GM3–GM3 glycan ligated clusters in our pH condi-
tions. Data showed that GM3 lactonization was rather minimal as 
the digestion of the sialic acid by sialidases, dramatically reduced 
surface GM3 detection at all pHs, which would not have been the 
case if detected clusters were predominantly lactones, as GM3 
lactones are resistant to such enzymatic treatment (Figure S13 in 
Supplementary Material) (67).
gM3 clustering antibody can Partially 
Mimic the Very low ph-induced 
Biophysical effects to Promote non-
Oncogenic Differentiated condition
From the insights gained, we wanted to further test whether 
incubation of LN229 GBM cells with multivalent anti-GM3 IgM 
antibody can partially mimic the GM3 clustered phenotype as 
observed at the very low pH. We wanted also to test whether 
such treatment can enable differentiation of the tumor cells in 
the −veCD and +veCD, pH 7.4 and 6.2 oncogenic conditions.
FigUre 11 | continued
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FigUre 11 | continued 
anti-gM3 antibody and its additional synergism with cyclophilin a inhibitor mimics low ph-induced physicochemical effects promoting non-
oncogenic transformation. (a–D) Cells were incubated with either 20 µg of IgM Ab, anti-GM3 IgM antibody, or anti-GM3 antibody along with 5 nM of cyclophilin 
A inhibitor. Treatments were repeated after 24–30 h. DIC image panel for each condition shows that by about 33 h, massive cell blebbing (indicated by yellow 
arrows) was observed in all treatments but not in control antibody sets (also see Figures S14 and S17 in Supplementary Material). The blebbing was rapidly 
accompanied with cell rounding (red arrowhead), detachment from the substrate (yellow arrowhead), followed by secondary necrosis (cyan arrowhead), and 
anoikis-type cell death. Cellular built up of acid vacuoles is shown by magenta curved arrows. The anti-GM3 antibody and antibody plus cyclophilin A inhibitor 
treated cultures were fixed and probed for (i) surface GM3 clusters, (ii) relationship of GM3 clustered organization with cortical and intracellular actin network (via 
Rhodamine phalloidin staining), and (iii) impact of GM3 clusters on the status of differentiation-associated protein (GFAP). Note that the Pearson’s colocalization 
coefficient (R) between GM3 and GFAP in all treatments (anti-GM3 Ab alone or anti-GM3 Ab + cyclophilin A inhibitor) was >0.7 ± SD and hence was significant. The 
experiment was repeated three times.
FigUre 12 | necrotic zones in glioblastoma patient samples show surface supraclustering of gM3 and underlying gFaP-positive filaments. Panel (a) 
shows (human) normal adult brain section with a negligible expression of GM3. GFAP, a filamentous protein and an astrocytic marker, is normally expressed in the 
brain. Necrotic zone in pediatric glioblastoma multiforme (GBM) patients is shown in panels (B,c), and necrotic zones in adult GBM patient tissue is shown in panel 
(D). Panels (B–D) show high surface clustering of GM3 and GFAP in the corresponding areas. (e) Grade IV GBM non-necrotic tumor growth areas (cellular tumor 
zone) show heterogeneous clustering of GM3 and GFAP unlike supraclustered organization at the necrotic and peri-necrotic zones.
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FigUre 13 | experimental confirmation of anti-gM3 antibody-mediated anoikis in other aggressive glioblastoma tumor cell lines. Glioblastoma cells 
(a) U87MG and (B) U373 at oncogenic pH ranges along with (c) normal cells: HaCaT (immortalized epidermal keratinocytes), mouse cerebellar granule neurons 
and mouse cortical astrocytes were treated with anti-GM3 antibody. Results showed 100% anoikis in only glioblastoma cells post 48 h treatment, but no signs of 
anoikis were visible in normal cells. Note that mouse neurons and astrocytes were fixed after the experiment and labeled with Tuj1 and GFAP antibodies, 
respectively, to reveal the morphologies clearly. The immunostained images are shown in grayscale. The experiment was repeated three times. (D) The deduced 
working model hence suggests that differential pH-induced cell fate competencies can all collapse into anoikis-driven cell death by regimes that can generate 
surface GM3 supraclustering/extensive cross-linking.
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For this, we incubated the confluent tumor cell cultures with 
20 µg of antibody in 300 µl of medium per well in the eight-well 
chamber slides. In 24  h, no visible morphological effects were 
observed over the isotype antibody control. When the next 
antibody shot was given, within 1.5 h, we began to observe mas-
sive cellular blebbing that was further enhanced by the next 3 h 
(Figure 11A, DIC image panel). The blebs were akin to what were 
seen at very low pH in our acid stress test (Figure 2B), but the 
number of levitated blebs and cells were far more in any field of 
microscopic view suggesting a buildup of high membrane tension 
which was released by the cells via blebbing.
The antibody-incubated cultured cells were fixed and probed 
for GM3 surface clusters, and the impact of this organization 
on the cortical and intracellular actin networks as well as on the 
status of differentiation-associated gene ‘GFAP’ were examined. 
The cells were fixed within 26  h of antibody treatment (for 
immunostaining-based analysis) as almost 100% anoikis was 
observed in 50–60 h post-treatment.
We find that in blebbed conditions (Figure 11), GM3 clusters 
were formed and were akin to those seen at the very low pH in 
the acid stress experiments (Figure 10A). These results also sug-
gest that anti-GM3 antibody may have generated GM3 tilts akin 
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to those observed in our simulation studies for the very low pH 
condition.
The cytoskeleton too was similarly disrupted as observed 
in the acid stress experiments (Figure S9 in Supplementary 
Material), and an appreciable increase in GFAP staining was seen 
(Figure  11). However, the GFAP appeared to be bundled and 
accumulated in certain regions of the cells, which was not the 
case when experimental conditions were incubated with isotype-
specific IgM antibody alone (Figure S14 in Supplementary 
Material). These clustered GFAP rich regions were found to be 
intriguingly enriched in GM3 clusters that were generated by 
the anti-GM3 antibody-mediated cross-linking. Hence, the cells 
could be effectively forced into a differentiated state via the GM3 
antibody-mediated clustering at both physiological and low 
pHs. The loss of protumorigenic receptors and signaling lattices 
through extensive surface blebbing could be one of the possible 
causes for this differentiation-like state.
Indeed, necrotic and peri-necrotic zones (associated with 
low pH environments) in glioblastoma patient samples showed 
extensive GM3 and GFAP colocalization and supraclustering 
(Figure 12), which was not seen in the non-necrotic zones of the 
tumor mass (see R values). The clusters in the non-necrotic zones 
were small and spread throughout the cells or were small and 
polarized. Hence, these results show that not just GM3 but GM3 
supraclustered conformations must be associated with the tumor 
cell death.
gM3 supraclustering along with the 
cyclophilin a inhibition May Be a Useful 
non-cytolytic antitumor Therapy for gBMs
Inhibition of cyclophilin binding to its surface receptors by 
cyclosporin A has been evidenced to impact GFAP expression 
(68). Cyclophilin A is found to be highly expressed in gliomas 
(Figure S16 in Supplementary Material, GBM patient data on 
CyPA expression). In our acid stress experiments, cyclophilin A 
(CyPA) release or secretion was found to be highly reduced at the 
very low pH and GFAP expression was enhanced (Figure S15 in 
Supplementary Material; Figure 6D).
We observed that a potent cyclophilin A inhibitor (69) at a very 
low concentration of 5 nM could inhibit CyPA release and induced 
appreciable tumor cell blebbing (Figure S17 in Supplementary 
Material, DIC image inset panels). This was accompanied by 
an increase in membranous GFAP and GM3 supraclustering; 
however, the cytoskeleton did not show an extensive rupturing 
as seen with anti-GM3 antibody treatment. The inhibitor treated 
cells showed massive stress fibers, indicative of high surface 
mechanical stress (Figure S17 in Supplementary Material). It is 
to be noted that the inhibitor treatment was observed to increase 
the intracellular concentration of cyclophilin A, suggesting an 
inhibitory action on the extracellular release of CyPA. The time 
frame for the recording of this observation was as follows: the first 
inhibitor shot: 24 h; second shot: 3 h.
To enhance the supraclustering effects, we incubated the anti-
GM3 antibody and cyclophilin A inhibitor together and found 
far prominent cell surface blebbing accompanied by an extensive 
rupture of the cytoskeleton (Figure  11). In this combination 
treatment, the GFAP expression was more enhanced than in the 
conditions with the anti-GM3 antibody alone and GFAP showed 
both surface anchored and sub-surface accumulation in the cor-
responding GM3 clustered areas.
As GFAP is a membranous and also cytoplasmic cytoskeletal 
protein, high surface mechanical stress probably influenced its 
integrity; however, GFAP enhanced expression indicated that cells 
might have switched their fate to more differentiated phenotypes. 
Thus a combination of anti-GM3 antibody and cyclophilin A 
inhibitor was more potent than anti-GM3 antibody alone in first 
causing cell differentiation and then forcing it to die by anoikis 
over the course of time (about 30–50  h post treatments). We 
further find that other GBM cell lines, U87MG and U373, when 
treated in a like manner, showed similar anoikis phenotype while 
normal cells such as epidermal keratinocytes (HaCaT), mouse 
astrocytes, and neurons were unaffected (Figures 13A–C). Hence, 
indeed manipulation of surface GM3 via cross-linking served as 
an effective therapeutics to eradicate not only low pH zones but 
also the tumor cells that were growing in physiological pH micro-
environments. This combination treatment hence converged the 
tumor cell heterogeneity into anoikis zones (Figure 13D).
DiscUssiOn anD cOnclUsiOn
The major goals of this study were (1) to identify how glioblas-
toma tumor cells respond to changes in the extracellular pH 
ranges leading to the heterogeneous cell fates; (2) how very 
low pHe causes growth arrest and (3) whether such identified 
growth arrest mechanisms can be simulated in the oncogenic 
pH environments, hijacking their biophysical homeostasis and 
molecular response machineries, to further transform them 
into the non-oncogenic phenotype (4) and force them to die 
by anoikis (a  de-adhesion induced cell death), which could be 
further followed by secondary necrosis that permits better in vivo 
system clearance of the dead cells.
The above mentioned queries were answered by two major 
findings that generated crucial insights into the role of surface 
lipids as targets in acidosis and in anticancer therapeutics.
The first finding indicated that pHe ranges exhibit differential 
capacities to modulate glioblastoma cell fate dynamics in a 
cholesterol-sensitive manner. Data showed that (1) lowering of 
pHe raised surface cholesterol probably as an adaption to prevent 
acid hydrolysis of the plasma membrane. A concomitant rise 
in proliferation index was observed for low pH conditions. (2) 
Tumor cells at physiological pH, when chemically manipulated to 
raise surface cholesterol, also showed enhanced proliferation. (3) 
High cholesterol containing tumor cells in pH microenvironment 
of 6.2 units showed highest proliferation competencies. Hence, 
high cholesterol seemed to increase the proliferation potential.
On the contrary, basal cholesterol tumor cells at pH 7.4 showed 
maximum migration competence and anchorage-independent 
growth (which is associated with the emergence of more stem-
like properties). Biophysical and molecular characterizations 
suggested that rise in cholesterol may have led to surface rigidity 
which supports proliferation but de-promotes stem-like charac-
teristics (70, 71). Very low pH at 3.4 units showed very high cho-
lesterol accumulation on the plasma membrane and an immense 
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rise in surface rigidity with the loss of cortical actin and focal 
contacts. Due to these changes, the ‘very low’ pH exposed tumor 
cells may have gradually levitated from the surface and died via 
anoikis-a ‘loss of anchorage’ mediated cell death. Interestingly, 
when the protective umbrella of enhanced surface cholesterol 
was removed from the low and very low pH microenvironments, 
the tumor cells underwent rapid anoikis, while physiological pH-
adapted cells were unharmed. These results suggest that surface 
cholesterol plays a crucial role in tumor cell adaptation to acidosis 
and can be developed into a prognostic and diagnostic marker.
The second main finding took leads from the first and 
describes how extracellular pH levels–cholesterol cross talk 
impacts the GM3 glycosphingolipid surface clustering, wherein 
very high proton concentration-driven and cholesterol-sensitive 
GM3–GM3 ligations were capable of generating strong substrate 
de-adhesion forces, levitating the tumor cells and hence driving 
tumor cell fate to anoikis type of cell death. The work further 
describes how insights from proton concentration-driven GM3 
supraclustering mechanisms inspired us to take an alternative 
approach to generate GM3 supraclusters via synergistic applica-
tion of anti-GM3 antibody to first potentiate the oncogenic tumor 
cell niches into differentiation and then into subsequent cell 
death, hence presenting novel insights into tumor therapeutics.
Anti-GM3 antibody probably cross-linked surface GM3 
molecules and produced high mechanical pressure as evidenced 
by blebbing on the tumor surface via GM3 supraclustering effects 
(Figure 11). This effect was accompanied by high expression and 
clustering of the underlying GFAP-positive filaments and ruptur-
ing of F-actin fibers that further diminished the substrate adhe-
sion and levitated the cells. This suggests that due to the probable 
transbilayer coupling (72), the surface clustering phenomena 
also clustered the underlying modules and mechano-transduced 
high pressure stress, damaging the stress fibers, and leading 
to the non-tumorigenic fate. These levitated cells eventually 
underwent secondary necrosis and cell death over the course of 
time. In concert with our results, GFAP high tumor cells are also 
found to be non-tumorigenic in the animal tumor graft models 
(73). Indeed, the GM3 supraclustered zones were identified in 
the necrotic regions of glioblastoma patient samples which also 
showed extensive GFAP protein clustering (Figure 12).
Cyclophilin inhibitors have been shown to stabilize GFAP 
(68). Upon the inhibition of cyclophilin A release, we found the 
phenotypic changes to be akin to those produced by the anti-GM3 
antibody treatments; however, the extent of F-actin damage was 
less. We did not test the mechanism by which CypA directly 
impacts GM3 clustering. However, GM3 is a well-known lipid raft-
associated glycosphingolipid and cyclophilin A interacts with the 
inner leaflet-associated annexin proteins that are in turn involved 
in PIP2-mediated lipid raft clustering (74). Given the recent reports 
that outer and inner membrane leaflets are coupled, ‘intracellularly 
trapped’ cyclophilin A [via use of cyclophilin A release inhibitor 
(Figure S16 in Supplementary Material)] might have additionally 
aided in GM3 supraclustering on the outer leaflet.
Indeed, upon the synergistic use of the anti-GM3 antibody 
and cyclophilin A inhibitor, the effects on anoikis-mediated cell 
death were enhanced in comparable time points vs. individual 
treatments of the oncogenic pH microenvironments (Figure 11).
The anti and pro-tumorigenic roles of GM3 have been dem-
onstrated via the RNA interference studies on GM3 synthase, 
an enzyme that enables synthesis of GM3 (75–78). Such studies, 
unfortunately, do not consider the fact that GM3 can be synthesized 
de novo from the higher polysialic acid containing gangliosides 
via the surface resident sialidases that are abundantly expressed 
in tumor cells (17). Indeed, GM3 and GM3 lactone agonist, as 
well as sialic acid-clustered GM3 lipid feeding has been shown to 
cause tumor cell death (66, 79–81). However, the direct feeding 
of GM3/clustered GM3 for therapeutics is highly undesirable, 
especially for the brain tumors, as this can be incorporated into 
the neurons and enough evidence suggest that GM3 in neurons 
can cause neuronal degeneration (82). This might be the reason 
why postnatal brain does not synthesize GM3 (83). Therefore, 
undoubtedly, it is not just the levels or the presence vs. absence 
but the ‘conformational changes of GM3’ on the tumor surface 
which should be majorly responsible for its differential effects 
on cell fate and this property should be exploited for anticancer 
therapeutics.
Given the fact that several tumors express GM3 and cyclophi-
lin A, a therapy composed of anti-GM3 antibody and cyclophilin 
A inhibitor may not be just limited to brain tumors as demon-
strated in this study but may also enable the regression of various 
tumor types as GM3 is expressed in several other tumors such as 
melanomas (84, 85), bladder (86), ovarian (75), colorectal (80), 
colon (87), prostate (88), lung (89), lymphoma (90), hepatic (91), 
renal (92), and breast cancers (93).
Interestingly, there are growing evidences that majority of 
tumors engineer acidic microenvironment for survival and 
invasion and clinical techniques such as acidoCEST MRI are 
now being employed to measure tumor extracellular pH for 
prognosis purposes (http://camel.arizona.edu/research/publica-
tions) (8, 9). Hence, our pursuit on understanding the cross 
talk between differential extracellular proton concentration and 
tumor cell cholesterol–GM3 dynamics, in fine tuning tumor cell 
heterogeneities and cell fates, should provide a strong impetus 
to include the measurements of surface cholesterol–GM3 levels 
in acidoCEST MRI-based prognosis. This may also generate 
additional insights into combination therapeutics based on the 
knowledge of proton–lipid–tumor cell fate dynamics.
A recent report (http://meetinglibrary.asco.org/print/ 
2387331, also see 94) also brings forth the importance of manipu-
lating tumor cell pH to induce cell death via photodynamically 
inducing proton release from tumor cells. However, the mecha-
nism by which extracellular protons can manipulate tumor cell 
surface and downstream cell fate needed elucidation. Hence, our 
work also mechanistically complements the above report. Our 
observations further caution that very high concentration of 
protons will be required for direct acid-driven therapies; other-
wise, it may lead to further promotion of oncogenesis (95, 96). 
Since protons are also diffusible, such direct acid stress therapies 
may also pose threats to the surrounding normal tissues, if not 
kept strictly restricted to tumor tissue; hence, the indispensabil-
ity of mimicking acidosis-driven tumor cell death mechanisms 
mediated through tumor surface remodeling principles, as dem-
onstrated here needs to be further developed for both solid and 
liquid tumors toward novel anticancer therapeutics.
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